Skip to main content
JIANGSU SIHUAN BIOENGINEERING CO.,LTD logo

JIANGSU SIHUAN BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000518 ISIN · CNE0000001P8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,779 across all filing types
Latest filing 2020-04-15 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000518

About JIANGSU SIHUAN BIOENGINEERING CO.,LTD

https://www.000518shsw.com

Jiangsu Sihuan Bioengineering Co., Ltd. specializes in the research, development, and production of biopharmaceutical products and traditional Chinese medicines. The company’s core product line features genetic engineering drugs, including recombinant human interleukin-2 (rhIL-2) and recombinant human granulocyte colony-stimulating factor (rhG-CSF). Its manufacturing capabilities encompass various dosage forms such as injections, capsules, and tablets, adhering to rigorous quality standards. In addition to its pharmaceutical core, the company manages ecological restoration and landscape engineering initiatives. The organization focuses on leveraging biotechnology to provide therapeutic solutions for oncology and immune-related conditions, maintaining a commitment to scientific innovation and clinical efficacy.

Recent filings

Filing Released Lang Actions
第八届监事会第十四次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement from Jiangsu Sihuan Bio Co., Ltd. regarding the resolutions passed at the 14th meeting of the 8th Supervisory Board. It includes details about the resignation of a supervisor and the election of a new supervisor candidate, as well as the proposal to convene an extraordinary general meeting. The content focuses on board/management changes and meeting resolutions, with no financial data or report attachments. The document length is short (1013 characters), and it is clearly an announcement of board/management changes rather than a full report or financial statement. Therefore, the appropriate classification is Board/Management Information (MANG).
2020-04-15 Chinese
2019年度业绩快报
Earnings Release Classification · 95% confidence The document is titled as a '2019年度业绩快报' which translates to '2019 Annual Performance Express Report' or 'Earnings Quick Report'. It contains preliminary financial data for the year 2019, including revenue, profit, net income, and other key financial metrics. The document explicitly states that the data is preliminary and may differ from the final annual report. It also mentions that the full 2019 annual report is still being prepared and will be published later. The document is relatively short (1473 characters) and serves as an initial earnings announcement rather than a full annual report. Therefore, it fits the definition of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. FY 2019
2020-04-15 Chinese
关于召开2020年第一次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about convening the 2020 first extraordinary general meeting of shareholders for Jiangsu Sihuan Bioengineering Co., Ltd. It includes details about the meeting date, voting methods (onsite and online), attendees, agenda items (such as the proposal to add a supervisor), and procedural instructions for voting. There are no financial statements, earnings data, or management discussion of financial results. The document is a formal announcement to shareholders about the meeting and how to participate and vote. It is not a report of voting results, nor is it a proxy solicitation or remuneration report. The document length is under 5,000 characters and it serves as a meeting notice. Therefore, it fits the category of a shareholder meeting notice, which corresponds to AGM Information (AGM-R).
2020-04-15 Chinese
监事辞职公告
Board/Management Information Classification · 95% confidence The document is a resignation announcement of a company supervisor (监事辞职公告) from 江苏四环生物股份有限公司. It details the resignation date, reason, and the impact on the supervisory board. There is no financial data, no mention of financial results, no regulatory certifications, or voting results. It is an announcement related to changes in company management structure, specifically the supervisory board. Therefore, it fits best under Board/Management Information (MANG). The document is short and focused solely on management change, not a report or regulatory filing.
2020-04-10 Chinese
关于持股5%以上股东减持股份的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a notification about a shareholder holding more than 5% of shares reducing their stake in the company. It details the shareholding changes, reduction amounts, prices, and confirms compliance with relevant securities laws. There is no financial report, earnings data, or management discussion. The document is a formal announcement of a major shareholding change, specifically a reduction by a significant shareholder. This fits the category of Major Shareholding Notification (MRQ). The document length is short and focused solely on shareholding changes, not a full report or announcement of a report publication.
2020-02-12 Chinese
关于股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding abnormal stock price fluctuations for the company 江苏四环生物股份有限公司 (stock code 000518). It discusses stock price movements, confirms no undisclosed material information, and references regulatory investigations and disclosures. The content is focused on stock trading behavior and regulatory compliance rather than financial results or detailed reports. The document length is short (1512 characters) and it is clearly an announcement about stock trading irregularities, not a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2020-02-11 Chinese

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.